Page last updated: 2024-08-18

arginine vasopressin and Acquired Nephrogenic Diabetes Insipidus

arginine vasopressin has been researched along with Acquired Nephrogenic Diabetes Insipidus in 74 studies

Research

Studies (74)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (4.05)	18.7374
1990's	20 (27.03)	18.2507
2000's	21 (28.38)	29.6817
2010's	22 (29.73)	24.3611
2020's	8 (10.81)	2.80

Authors

Authors	Studies
Bitencourt, L; de Oliveira Campos, JL; Drummond, JB; Fischer, BL; Simões E Silva, AC; Soares de Brito, SBC; Soares, BS; Vaz de Castro, PAS	1
Arnoux, G; Feraille, E; Martin, PY; Olivier, V; Sassi, A	1
Chernyakov, D; Edemir, B; Esteva-Font, C; Fenton, RA; Petrillo, F; Poulsen, SB	1
Asakura, K; Ito, H; Ogata, H; Omatsu, M; Yamamoto, M; Yoshida, K	1
Hureaux, M; Vargas-Poussou, R	1
Eremina, ER; Hamaganova, IR; Makretskaya, NA; Nanzanova, US; Tiulpakov, AN	1
Al-Jubair, T; Frick, A; Gourdon, P; Hagströmer, CJ; Hyld Steffen, J; Kreida, S; Törnroth-Horsefield, S	1
Bistrup, C; Hinrichs, GR; Jensen, BL; Mortensen, LA	1
Luger, A; Schernthaner-Reiter, MH; Stratakis, CA	1
Carmosino, M; Gerbino, A; Milano, S; Procino, G; Svelto, M	1
Ando, F; Kagechika, H; Kondo, Y; Mori, S; Morimoto, T; Nomura, N; Rai, T; Sasaki, S; Sohara, E; Uchida, S; Yui, N	1
Carlson, NG; Hansson, KM; Huang, Y; Kishore, BK; Liu, T; Magnell, K; Zhang, Y	1
Garrahy, A; Moran, C; Thompson, CJ	1
Armstrong, SP; Ayoub, MA; Feldman, BJ; Pfleger, KD; Seeber, RM	1
Cano-Peñalver, JL; de Frutos, S; Dedhar, S; Griera, M; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Serrano, I	1
Allolio, B; Arici, B; Christ-Crain, M; Fenske, W; Frech, N; Katan, M; Kopp, P; Kühn, F; Müller, B; Rutishauser, J; Stettler, C; Timper, K	1
Baqi, Y; Carlson, NG; Heiney, KM; Kishore, BK; Kohan, DE; Müller, CE; Peti-Peterdi, J; Strasburg, DL; Villanueva, K; Zhang, Y	1
Carlson, NG; Ecelbarger, CM; Kishore, BK; Kohan, DE; Müller, CE; Nelson, RD; Peti-Peterdi, J; Zhang, Y	1
Grunert, S; Labudde, D	1
Boukelmoune, N; Dhande, I; Doris, PA; Gonzalez-Garay, ML; Mamenko, M; Pochynyuk, O; Tomilin, V; Zaika, O; Zhu, Y	1
Beulshausen, S; Klussmann, E; Nedvetsky, PI; Rosenthal, W; Tamma, G; Valenti, G	1
Igarashi, T; Iida, A; Miura, K; Sekine, T; Takahashi, K	1
Eidne, KA; Feldman, BJ; Kocan, M; Pfleger, KD; Sampaio, NG; See, HB	1
Choi, YK; Jeon, JH; Kim, BW; Kim, HJ; Kim, JG; Kwon, TH; Lee, IK; Lee, JE; Lee, JY; Moon, SS; Seo, HA	1
Schrier, RW	1
De Mattia, F; Deen, PM; Kamsteeg, EJ; Konings, IB; Li, Y; Savelkoul, PJ; van der Sluijs, P	1
Boone, M; Deen, PM; Kortenoeven, M; Robben, JH	1
Bonnet, D; Durroux, T; Frantz, MC; Hibert, M; Jean-Alphonse, F; Loison, S; Méjean, C; Mendre, C; Morin, D; Mouillac, B; Perkovska, S	1
Bouvier, M; Carpentier, E; Chen, S; Gitelman, SE; Kovoor, A; Oligny-Longpré, G; Rochdi, MD; Rosenthal, SM; Vargas, GA; von Zastrow, M	1
Miller, WL; Rattanachartnarong, N; Sahakitrungruang, T; Shotelersuk, V; Suphapeetiporn, K; Tee, MK	1
Fenton, RA; Hammond, HK; Insel, PA; Murray, F; Rieg, T; Schroth, J; Tang, T; Vallon, V	1
Babey, M; Kopp, P; Robertson, GL	1
Beukinga, I; Decaux, G; Kornreich, A; Pradier, O; Vandergheynst, F; Vassart, G	1
Carlson, NG; Kishore, BK; Pop, IL; Zhang, Y	1
Heinke, F; Labudde, D	1
Devuyst, O	1
Fenton, RA; Moeller, HB; Rittig, S	1
KAPLAN, SA; STRAUSS, J; YUCEOGLU, AM	1
VESTERMARK, S	1
KAPLAN, SA; ROBINSON, MG	1
Kurtz, I; Nguyen, MK; Nielsen, S	1
de Mattia, F; Deen, PM; Kamsteeg, EJ; Konings, IB; Mallmann, R; Oksche, A; Savelkoul, PJ; van der Sluijs, P	1
Brown, D; McKee, M; Russo, LM	1
Ishikawa, SE; Sasaki, M	1
Bichet, DG	3
Noda, Y; Sasaki, S	1
Boson, WL; Correa, H; Damiani, D; De Marco, L; Della Manna, T; Friedman, E; Gadelha, MR; Liberman, B; Miranda, DM; Ribeiro, PA; Romano-Silva, MA; Silva, FF	1
Cheong, HI; Cho, HY; Choi, Y; Ha, IS; Park, HW	1
Inada, M; Matsubara, H; Mori, Y; Seido, T; Taketani, S; Tsukaguchi, H	1
Inada, M; Matsubara, H; Mori, Y; Nakao, K; Tsukaguchi, H; Yoshimasa, T; Yoshimasa, Y	1
Robertson, GL	1
Birnbaumer, M; Gilbert, S; Rosenthal, W	1
Bannai, C; Kawai, K; Kawakami, Y; Matsushima, T; Nishi, M; Odawara, M; Okuda, Y; Shimakura, S; Sone, H; Yamashita, K	1
Schoneberg, T; Wenkert, D; Wess, J; Yun, J	1
Ando, A; Imai, E; Itoh, T; Izumi, M; Kamada, T; Ueda, N; Yamauchi, A; Yokoyama, K	1
Birnbaumer, M; Dickson, J; Liebenhoff, U; Müller, H; Oksche, A; Rosenthal, W; Rutz, C; Schülein, R	1
Knoers, NV; Monnens, LA; Smits, P; van Lieburg, AF	1
Ishikawa, S	1
Goldsmith, PK; Merendino, JJ; Rodriguez Pena, MS; Schoneberg, T; Spiegel, AM; Vinitsky, R; Wenkert, D; Wess, J	1
Birnbaumer, M; Innamorati, G; Sadeghi, HM	1
Bichet, DG; Oksche, A; Rosenthal, W	1
Martin, PY; Schrier, RW	1
Ala, Y; Antignac, C; Barberis, C; Bichet, D; Cotte, N; Dechaux, M; Hendy, G; Hibert, M; Morin, D; Sabatier, N; Vargas, R	1
Boson, W; de Lacerda, L; De Marco, L; Figueiredo, B; Friedman, E; Graf, H; Liberman, B; Martins, S; Moreira, A; Puñales, MK; Rocha, JL; Sandrini, R	1
Fukui, T; Fukuno, H; Kinoshita, M; Sato, K; Sawada, S; Taniguchi, T	1
Evrard, A; Lefebvre, J; Vantyghem, M	1
Angers, S; Arthus, MF; Bernier, V; Bichet, DG; Bouvier, M; Laperrière, A; Lonergan, M; Morello, JP; Morin, D; Petäjä-Repo, U; Salahpour, A	1
Filler, G; Grüters, A; Hoeltzenbein, M; Jääskeläinen, J; Linnemann, K; Pasel, K; Schöneberg, T; Schulz, A; Timmermann, K	1
Deen, PM; Kamsteeg, EJ; van Balkom, BW	1
Barak, LS; Caron, MG; Laporte, SA; Oakley, RH	1
Deen, PM; Knoers, NV	1
Fujiwara, T; Hiramori, K; Kawamura, M; Kimura, Y; Owada, M; Sasaki, S; Uchida, S	1

Reviews

25 review(s) available for arginine vasopressin and Acquired Nephrogenic Diabetes Insipidus

Article	Year
Nephrogenic diabetes insipidus: a comprehensive overview. Journal of pediatric endocrinology & metabolism : JPEM, 2022, Apr-26, Volume: 35, Issue:4 Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus; Humans; Mutation; Polyuria; Quality of Life	2022
Renal water transport in health and disease. Pflugers Archiv : European journal of physiology, 2022, Volume: 474, Issue:8 Topics: Aquaporin 2; Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Humans; Hyponatremia; Water	2022
Genetic basis of nephrogenic diabetes insipidus. Molecular and cellular endocrinology, 2023, 01-15, Volume: 560 Topics: Aquaporin 2; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Humans; Mutation; Receptors, Vasopressin	2023
A mini-review of pharmacological strategies used to ameliorate polyuria associated with X-linked nephrogenic diabetes insipidus. American journal of physiology. Renal physiology, 2020, 11-01, Volume: 319, Issue:5 Topics: Animals; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus; Humans; Polyuria; Protein Transport; Receptors, Vasopressin	2020
Genetics of Diabetes Insipidus. Endocrinology and metabolism clinics of North America, 2017, Volume: 46, Issue:2 Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Humans; Pituitary Gland, Posterior	2017
Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update. International journal of molecular sciences, 2017, Nov-10, Volume: 18, Issue:11 Topics: Aquaporin 2; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Exocytosis; Humans; Mutation; Receptors, Vasopressin	2017
Diagnosis and management of central diabetes insipidus in adults. Clinical endocrinology, 2019, Volume: 90, Issue:1 Topics: Adult; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Diabetes Insipidus, Neurogenic; Diagnosis, Differential; Disease Management; Glycopeptides; Humans; Polydipsia, Psychogenic	2019
Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus. Acta physiologica (Oxford, England), 2015, Volume: 214, Issue:2 Topics: Animals; Aquaporins; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Humans; Lithium; Natriuresis; Receptors, Purinergic P2Y2	2015
Regulation of aquaporin-2 trafficking. Handbook of experimental pharmacology, 2009, Issue:190 Topics: A Kinase Anchor Proteins; Animals; Aquaporin 2; Arginine Vasopressin; Calcium; Cell Compartmentation; Cell Membrane; Cyclic AMP; Cytoskeleton; Diabetes Insipidus, Nephrogenic; Endocytosis; Homeostasis; Humans; Kidney Tubules, Collecting; Phosphoric Diester Hydrolases; Phosphorylation; Protein Transport; Signal Transduction; Water; Water-Electrolyte Balance	2009
Familial forms of diabetes insipidus: clinical and molecular characteristics. Nature reviews. Endocrinology, 2011, Jul-05, Volume: 7, Issue:12 Topics: Animals; Aquaporin 2; Arginine Vasopressin; Deamino Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Diabetes Insipidus, Neurogenic; Diagnosis, Differential; Female; Humans; Male; Mutation; Phenotype; Polydipsia; Polyuria; Receptors, Vasopressin; Vasopressins	2011
Physiopathology and diagnosis of nephrogenic diabetes insipidus. Annales d'endocrinologie, 2012, Volume: 73, Issue:2 Topics: Aquaporin 2; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Humans; Mutation; Receptors, Vasopressin	2012
Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment. Endocrine reviews, 2013, Volume: 34, Issue:2 Topics: Animals; Aquaporin 2; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Humans; Mutation; Rats; Receptors, Vasopressin	2013
Molecular pathogenesis of nephrogenic diabetes insipidus. Clinical and experimental nephrology, 2003, Volume: 7, Issue:1 Topics: Animals; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Gene Expression Regulation; Genetic Linkage; Humans; Mutation; Receptors, Vasopressin; Signal Transduction; X Chromosome	2003
[Renal action of vasopressin]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Benzazepines; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Drug Design; Humans; Hyponatremia; Inappropriate ADH Syndrome; Mutation; Piperidines; Quinolones; Receptors, Vasopressin	2006
Nephrogenic diabetes insipidus. Advances in chronic kidney disease, 2006, Volume: 13, Issue:2 Topics: Aquaporin 2; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; DNA; Humans; Mutation; Receptors, Vasopressin	2006
Regulation of aquaporin-2 trafficking and its binding protein complex. Biochimica et biophysica acta, 2006, Volume: 1758, Issue:8 Topics: Actins; Animals; Aquaporin 2; Arginine Vasopressin; Calcium; Cell Membrane; Cell Polarity; Cyclic AMP; Cytoskeleton; Diabetes Insipidus, Nephrogenic; Endocytosis; GTPase-Activating Proteins; Humans; Kidney Tubules, Collecting; Mutation; Phosphorylation; Protein Binding; Protein Structure, Tertiary; Protein Transport	2006
Nephrogenic diabetes insipidus. Seminars in nephrology, 1994, Volume: 14, Issue:4 Topics: Amino Acid Sequence; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Female; Genetic Linkage; Humans; Male; Molecular Sequence Data; Mutation; Receptors, Vasopressin; X Chromosome	1994
The use of vasopressin assays in physiology and pathophysiology. Seminars in nephrology, 1994, Volume: 14, Issue:4 Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Humans; Immunoassay; Inappropriate ADH Syndrome; Water-Electrolyte Balance; Water-Electrolyte Imbalance	1994
[Nephrogenic diabetes insipidus]. Nihon rinsho. Japanese journal of clinical medicine, 1996, Volume: 54, Issue:3 Topics: Adenylyl Cyclases; Animals; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Cyclic AMP; Diabetes Insipidus, Nephrogenic; Humans; Ion Channels; Kidney Tubules; Mutation; Receptors, Vasopressin	1996
Congenital nephrogenic diabetes insipidus. Journal of the American Society of Nephrology : JASN, 1997, Volume: 8, Issue:12 Topics: Amino Acid Sequence; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Deamino Arginine Vasopressin; Dehydration; Diabetes Insipidus, Nephrogenic; Drug Resistance; Female; Founder Effect; Genetic Carrier Screening; Genetic Heterogeneity; History, 17th Century; History, 18th Century; Humans; Incidence; Infant; Infant, Newborn; Intellectual Disability; Ion Channels; Ireland; Kidney Failure, Chronic; Male; Models, Biological; Models, Molecular; Molecular Sequence Data; Mutation; Nephrons; Nova Scotia; Prenatal Diagnosis; Prevalence; Protein Conformation; Receptors, Vasopressin; X Chromosome	1997
Role of aquaporin-2 water channels in urinary concentration and dilution defects. Kidney international. Supplement, 1998, Volume: 65 Topics: Animals; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Heart Failure; Humans; Ion Channels; Kidney Concentrating Ability; RNA, Messenger	1998
Nephrogenic diabetes insipidus. The American journal of medicine, 1998, Volume: 105, Issue:5 Topics: Aquaporins; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; GTP-Binding Proteins; Humans; Mutation; Oxytocin; Protein Binding; Protein Structure, Tertiary; Receptors, Vasopressin; Vasopressins	1998
[Nephrogenic diabetes insipidus]. Annales d'endocrinologie, 1999, Volume: 60, Issue:6 Topics: Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Drug Resistance; Genetic Linkage; Humans; Kidney Concentrating Ability; Mutation; Receptors, Vasopressin; X Chromosome	1999
Routing of the aquaporin-2 water channel in health and disease. European journal of cell biology, 2000, Volume: 79, Issue:8 Topics: Animals; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Cell Compartmentation; Diabetes Insipidus, Nephrogenic; Humans; Hypotension; Kidney Tubules, Collecting; Mutation; Protein Transport; Signal Transduction; Water-Electrolyte Balance	2000
[From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus]. Nederlands tijdschrift voor geneeskunde, 2000, Dec-09, Volume: 144, Issue:50 Topics: Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Chromosomes, Human, Pair 12; Diabetes Insipidus, Nephrogenic; Genetic Linkage; Genetic Predisposition to Disease; Humans; Mutation; Receptors, Vasopressin; X Chromosome	2000

Other Studies

49 other study(ies) available for arginine vasopressin and Acquired Nephrogenic Diabetes Insipidus

Article	Year
Genetic deletion of the nuclear factor of activated T cells 5 in collecting duct principal cells causes nephrogenic diabetes insipidus. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2022, Volume: 36, Issue:11 Topics: Animals; Aquaporin 2; Arginine Vasopressin; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus; Factor V; Kidney Tubules, Collecting; Mice; Receptors, Vasopressin; T-Lymphocytes; Transcription Factors; Vasopressins; Water	2022
A case of nephrogenic diabetes insipidus likely caused by anti-neutrophil cytoplastic antibody-associated vasculitis. CEN case reports, 2023, Volume: 12, Issue:2 Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus; Humans; Male; Nephritis, Interstitial; Polyuria; Vasculitis	2023
[Clinical and laboratory characteristics of arginine vasopressin resistance, caused by a new homozygous mutation p.R113C in AQP2]. Problemy endokrinologii, 2023, May-12, Volume: 69, Issue:2 Topics: Aquaporin 2; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Humans; Mutation; Vasopressins	2023
Structural and functional analysis of aquaporin-2 mutants involved in nephrogenic diabetes insipidus. Scientific reports, 2023, 09-06, Volume: 13, Issue:1 Topics: Aquaporin 2; Arginine Vasopressin; Biological Assay; Biophysics; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus; Humans	2023
AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus. Nature communications, 2018, 04-12, Volume: 9, Issue:1 Topics: A Kinase Anchor Proteins; Amino Acid Sequence; Animals; Aquaporin 2; Arginine Vasopressin; Benzazepines; Benzhydryl Compounds; Cell Line, Transformed; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Epithelial Cells; Gene Expression Regulation; Humans; Kidney Tubules, Collecting; Male; Mice, Inbred C57BL; Osmolar Concentration; Phenols; Protein Binding; Receptors, Vasopressin; Tolvaptan; Water	2018
Genetic deletion of ADP-activated P2Y Acta physiologica (Oxford, England), 2019, Volume: 225, Issue:2 Topics: Animals; Aquaporin 2; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Dinoprostone; Female; Lithium; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Natriuresis; Potassium; Receptors, Purinergic P2Y12	2019
Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V). PloS one, 2013, Volume: 8, Issue:6 Topics: Animals; Aquaporin 2; Arginine Vasopressin; Arrestins; beta-Arrestins; Chlorocebus aethiops; COS Cells; Cyclic AMP; Diabetes Insipidus, Nephrogenic; Gene Expression Regulation; Genetic Diseases, X-Linked; GTP-Binding Protein alpha Subunits, Gs; HEK293 Cells; Humans; Inappropriate ADH Syndrome; Inositol Phosphates; Mutation; Polymorphism, Genetic; Receptors, Vasopressin; Signal Transduction	2013
Integrin-linked kinase regulates tubular aquaporin-2 content and intracellular location: a link between the extracellular matrix and water reabsorption. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2014, Volume: 28, Issue:8 Topics: Animals; Aquaporin 2; Aquaporin 3; Arginine Vasopressin; Biological Transport, Active; Body Water; Cell Membrane; Cell Polarity; Cells, Cultured; Collagen Type I; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Extracellular Matrix Proteins; Kidney Concentrating Ability; Kidney Tubules, Collecting; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Osmolar Concentration; Osmotic Pressure; Phosphorylation; Polyuria; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Receptors, Vasopressin; RNA Interference; RNA, Small Interfering	2014
Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study. The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:6 Topics: Adult; Arginine Vasopressin; Cohort Studies; Diabetes Insipidus, Nephrogenic; Diabetes Insipidus, Neurogenic; Diagnosis, Differential; Female; Glycopeptides; Humans; Male; Middle Aged; Polydipsia; Polyuria; Sensitivity and Specificity; Syndrome; Water Deprivation	2015
P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus. Journal of the American Society of Nephrology : JASN, 2015, Volume: 26, Issue:12 Topics: Animals; Aquaporin 2; Arginine Vasopressin; Clopidogrel; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Kidney Concentrating Ability; Kidney Medulla; Kidney Tubules, Collecting; Lithium; Male; Purinergic P2Y Receptor Antagonists; Rats; Rats, Brattleboro; Rats, Sprague-Dawley; Receptors, Purinergic P2Y12; RNA, Messenger; Ticlopidine; Water	2015
Evolutionary Influenced Interaction Pattern as Indicator for the Investigation of Natural Variants Causing Nephrogenic Diabetes Insipidus. Computational and mathematical methods in medicine, 2015, Volume: 2015 Topics: Algorithms; Aquaporin 2; Arginine Vasopressin; Biomarkers; Computational Biology; Computer Graphics; Databases, Protein; Diabetes Insipidus, Nephrogenic; DNA Mutational Analysis; Evolution, Molecular; Humans; Imaging, Three-Dimensional; Mutation; Phosphorylation; Pituitary Gland; Protein Conformation; Protein Folding; Proteomics; Receptors, Vasopressin	2015
Defective Store-Operated Calcium Entry Causes Partial Nephrogenic Diabetes Insipidus. Journal of the American Society of Nephrology : JASN, 2016, Volume: 27, Issue:7 Topics: Animals; Aquaporin 2; Arginine Vasopressin; Calcium Channels; Cells, Cultured; Diabetes Insipidus, Nephrogenic; Male; Rats; Rats, Inbred SHR; Stromal Interaction Molecule 1	2016
Salt-losing nephrogenic diabetes insipidus caused by fetal exposure to angiotensin receptor blocker. Pediatric nephrology (Berlin, Germany), 2009, Volume: 24, Issue:6 Topics: Angiotensin II Type 1 Receptor Blockers; Arginine Vasopressin; Aspartic Acid; Child; Child, Preschool; Cyclic AMP; Diabetes Insipidus, Nephrogenic; Female; Glomerular Filtration Rate; Humans; Kidney Function Tests; Male; Peritoneal Dialysis; Pregnancy; Prenatal Exposure Delayed Effects; Renal Insufficiency; Sodium Chloride Symporter Inhibitors; Treatment Outcome; Trichlormethiazide	2009
Agonist-independent interactions between beta-arrestins and mutant vasopressin type II receptors associated with nephrogenic syndrome of inappropriate antidiuresis. Molecular endocrinology (Baltimore, Md.), 2009, Volume: 23, Issue:4 Topics: Animals; Arginine Vasopressin; Arrestins; beta-Arrestins; Cell Line; Diabetes Insipidus, Nephrogenic; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infant; Male; Microscopy, Confocal; Receptors, Vasopressin; Recombinant Fusion Proteins; Signal Transduction	2009
Novel mutation of aquaporin-2 gene in a patient with congenital nephrogenic diabetes insipidus. Endocrine journal, 2009, Volume: 56, Issue:7 Topics: Adolescent; Aquaporin 2; Arginine Vasopressin; Base Sequence; Diabetes Insipidus, Nephrogenic; Humans; Male; Molecular Sequence Data; Mutation, Missense	2009
Interactions between angiotensin II and arginine vasopressin in water homeostasis. Kidney international, 2009, Volume: 76, Issue:2 Topics: Adenylyl Cyclases; Angiotensin II; Animals; Aquaporin 2; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 3; Phosphorylation; Polyuria; Receptor, Angiotensin, Type 1; Urine; Water-Electrolyte Balance	2009
p.R254Q mutation in the aquaporin-2 water channel causing dominant nephrogenic diabetes insipidus is due to a lack of arginine vasopressin-induced phosphorylation. Human mutation, 2009, Volume: 30, Issue:10 Topics: Animals; Aquaporin 2; Arginine Vasopressin; Base Sequence; Biopolymers; Cell Membrane; Cells, Cultured; Diabetes Insipidus, Nephrogenic; DNA Primers; Dogs; Genes, Dominant; Humans; Mutation; Phosphorylation	2009
Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine; Arginine Vasopressin; Atrial Natriuretic Factor; Cell Line; Cells, Cultured; Cyclic GMP; Diabetes Insipidus, Nephrogenic; Humans; Kidney Tubules, Collecting; Male; Models, Animal; Morpholines; Protein Biosynthesis; Receptors, Vasopressin; Signal Transduction; Spiro Compounds	2010
Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus. Journal of the American Society of Nephrology : JASN, 2009, Volume: 20, Issue:10 Topics: Arginine Vasopressin; Arrestin; Cells, Cultured; Cyclic AMP; Diabetes Insipidus, Nephrogenic; Glycosylation; Humans; MAP Kinase Signaling System; Molecular Chaperones; Receptors, Vasopressin	2009
Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments. Molecular pharmacology, 2010, Volume: 77, Issue:5 Topics: Amino Acid Substitution; Arginine; Arginine Vasopressin; Arrestins; beta-Arrestins; Cell Line; Cyclic AMP; Diabetes Insipidus, Nephrogenic; Histidine; Humans; Inappropriate ADH Syndrome; Kidney; Microscopy, Fluorescence; Mutagenesis; Mutation; Plasmids; Receptors, Vasopressin; Transfection	2010
Functional characterization of vasopressin receptor 2 mutations causing partial and complete congenital nephrogenic diabetes insipidus in Thai families. Hormone research in paediatrics, 2010, Volume: 73, Issue:5 Topics: Arginine Vasopressin; Asian People; Base Sequence; Cell Line; Child, Preschool; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Humans; Infant; Kidney Concentrating Ability; Male; Mutation; Mutation, Missense; Receptors, Vasopressin; Transfection	2010
Adenylate cyclase 6 determines cAMP formation and aquaporin-2 phosphorylation and trafficking in inner medulla. Journal of the American Society of Nephrology : JASN, 2010, Volume: 21, Issue:12 Topics: Adenylyl Cyclases; Animals; Aquaporin 2; Arginine Vasopressin; Blotting, Western; Cyclic AMP; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Kidney Medulla; Kidney Tubules, Collecting; Mice; Mice, Inbred Strains; Osmolar Concentration; Phosphorylation; Polymerase Chain Reaction; Random Allocation; RNA, Messenger; Sensitivity and Specificity; Water Deprivation; Water-Electrolyte Balance	2010
Lack of responsiveness to 1-desamino-D arginin vasopressin (desmopressin) in male patients with nephrogenic syndrome of inappropriate antidiuresis: from bench to bedside. European journal of clinical investigation, 2012, Volume: 42, Issue:3 Topics: Adult; Antidiuretic Agents; Arginine Vasopressin; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; DNA Mutational Analysis; Factor VIII; Female; Homeostasis; Humans; Inappropriate ADH Syndrome; Male; Middle Aged; Mutation; Pedigree; Receptors, Vasopressin; von Willebrand Factor; Water-Electrolyte Imbalance; Young Adult	2012
Genetic deletion of the P2Y2 receptor offers significant resistance to development of lithium-induced polyuria accompanied by alterations in PGE2 signaling. American journal of physiology. Renal physiology, 2012, Jan-01, Volume: 302, Issue:1 Topics: Animals; Aquaporin 2; Arginine Vasopressin; Cyclic AMP; Diabetes Insipidus, Nephrogenic; Dinoprostone; Female; Kidney Tubules, Collecting; Lithium Chloride; Male; Mice; Mice, Knockout; Polyuria; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Purinergic P2Y2	2012
Membrane protein stability analyses by means of protein energy profiles in case of nephrogenic diabetes insipidus. Computational and mathematical methods in medicine, 2012, Volume: 2012 Topics: Aquaporin 2; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Humans; Membrane Proteins; Mutation; Protein Stability; Receptors, Vasopressin; Structure-Activity Relationship	2012
Vasopressin-resistant diabetes insipidus. A.M.A. journal of diseases of children, 1959, Volume: 97, Issue:3 Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Diabetes Insipidus, Neurogenic; Humans; Medical Records; Vasopressins	1959
[Vasopressin-resistant diabetes insipidus]. Nordisk medicin, 1963, May-30, Volume: 69 Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Diabetes Insipidus, Neurogenic; Humans; Vasopressins	1963
Inheritance of vasopressin-resistant ("nephrogenic") diabetes insipidus. A.M.A. journal of diseases of children, 1960, Volume: 99 Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Humans; Vasopressins	1960
Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus. Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:10 Topics: Aquaporin 2; Arginine Vasopressin; Cells, Cultured; Child; Diabetes Insipidus, Nephrogenic; Humans; Male; Mutation; Oocytes; Pedigree; Phosphorylation; Protein Transport	2005
Methyl-beta-cyclodextrin induces vasopressin-independent apical accumulation of aquaporin-2 in the isolated, perfused rat kidney. American journal of physiology. Renal physiology, 2006, Volume: 291, Issue:1 Topics: Animals; Aquaporin 2; Aquaporin 3; Aquaporin 4; Arginine Vasopressin; beta-Cyclodextrins; Cytoplasmic Vesicles; Diabetes Insipidus, Nephrogenic; Endocytosis; Endopeptidases; Fluorescent Antibody Technique; Immunohistochemistry; Kidney; Male; Microscopy, Electron; Rats; Rats, Brattleboro; Rats, Sprague-Dawley; Receptors, Vasopressin; Signal Transduction; Vasopressins	2006
Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients. Genetic testing, 2006,Fall, Volume: 10, Issue:3 Topics: Amino Acid Sequence; Amino Acid Substitution; Arginine Vasopressin; Brazil; Diabetes Insipidus, Nephrogenic; Female; Humans; Male; Molecular Sequence Data; Mutation; Open Reading Frames; Pedigree; Receptors, Vasopressin	2006
Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones. Nephrology (Carlton, Vic.), 2007, Volume: 12, Issue:2 Topics: Animals; Arginine Vasopressin; Cell Membrane; Chlorocebus aethiops; COS Cells; Diabetes Insipidus, Nephrogenic; Dimethyl Sulfoxide; Humans; Male; Methylamines; Molecular Chaperones; Mutation; Mutation, Missense; Point Mutation; Protein Folding; Protein Transport; Receptors, Vasopressin; Temperature; Transfection	2007
Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus. The Journal of clinical investigation, 1995, Volume: 96, Issue:4 Topics: Amino Acid Sequence; Animals; Arginine Vasopressin; CHO Cells; Cricetinae; Diabetes Insipidus, Nephrogenic; Fluorescent Antibody Technique; Genetic Linkage; Immune Sera; Molecular Sequence Data; Mutation; Receptors, Vasopressin; X Chromosome	1995
Two vasopressin type 2 receptor gene mutations R143P and delta V278 in patients with nephrogenic diabetes insipidus impair ligand binding of the receptor. Biochemical and biophysical research communications, 1995, Jun-26, Volume: 211, Issue:3 Topics: Amino Acid Sequence; Animals; Arginine Vasopressin; Asian People; Base Sequence; Blotting, Northern; CHO Cells; Cricetinae; Cyclic AMP; Diabetes Insipidus, Nephrogenic; Dose-Response Relationship, Drug; Drug Resistance; Humans; Japan; Kinetics; Molecular Sequence Data; Mutation; Radioligand Assay; Receptors, Vasopressin; Recombinant Proteins	1995
An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system. Molecular endocrinology (Baltimore, Md.), 1994, Volume: 8, Issue:7 Topics: Adenylyl Cyclases; Amino Acid Sequence; Animals; Arginine Vasopressin; Base Sequence; Cell Line; Cell Membrane; Chlorocebus aethiops; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; GTP-Binding Proteins; Humans; L Cells; Mice; Molecular Sequence Data; Point Mutation; Protein Binding; Protein Conformation; Protein Processing, Post-Translational; Receptors, Vasopressin; Recombinant Fusion Proteins; Signal Transduction	1994
Transient nephrogenic diabetes insipidus accompanied by possible psychogenic polydipsia. Hormone research, 1995, Volume: 44, Issue:4 Topics: Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Diuresis; Drinking Behavior; Humans; Male; Middle Aged; Osmolar Concentration; Sodium; Urodynamics	1995
Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide. The EMBO journal, 1996, Mar-15, Volume: 15, Issue:6 Topics: Amino Acid Sequence; Arginine Vasopressin; Binding Sites; Biological Transport; Cell Compartmentation; Cyclic AMP; Diabetes Insipidus, Nephrogenic; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; GTP-Binding Proteins; Humans; Molecular Sequence Data; Mutation; Peptide Fragments; Receptors, Vasopressin; Recombinant Proteins; Signal Transduction	1996
A low-affinity vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus. Journal of the American Society of Nephrology : JASN, 1996, Volume: 7, Issue:3 Topics: Adult; Arginine Vasopressin; Base Sequence; Cell Line; Cyclic AMP; Diabetes Insipidus, Nephrogenic; DNA Mutational Analysis; Gene Expression Regulation; Genetic Linkage; Humans; Kidney; Male; Molecular Sequence Data; Mutagenesis, Site-Directed; Pedigree; Point Mutation; Receptors, Vasopressin; Renal Agents; X Chromosome	1996
Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function. Molecular pharmacology, 1996, Volume: 50, Issue:4 Topics: Alkaline Phosphatase; Amino Acid Sequence; Animals; Arginine Vasopressin; COS Cells; Diabetes Insipidus, Nephrogenic; Escherichia coli; Genetic Linkage; Humans; Immunoblotting; Kinetics; Molecular Sequence Data; Point Mutation; Receptors, Vasopressin; Transfection; Tritium; X Chromosome	1996
Effects of arginine vasopressin and 1-desamino-8-D arginine vasopressin on forearm vasculature of healthy subjects and patients with a V2 receptor defect. Journal of hypertension, 1995, Volume: 13, Issue:12 Pt 2 Topics: Adult; Arginine Vasopressin; Blood Flow Velocity; Brachial Artery; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Enzyme Inhibitors; Forearm; Humans; Hypoglycemic Agents; Male; omega-N-Methylarginine; Receptors, Vasopressin; Vasoconstrictor Agents	1995
Functional characterization of five V2 vasopressin receptor gene mutations. Molecular and cellular endocrinology, 1996, Nov-29, Volume: 124, Issue:1-2 Topics: Animals; Arginine Vasopressin; Cell Membrane; COS Cells; Cyclic AMP; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Humans; Kinetics; Mutation; Receptors, Vasopressin; Recombinant Fusion Proteins	1996
An X-linked NDI mutation reveals a requirement for cell surface V2R expression. Molecular endocrinology (Baltimore, Md.), 1997, Volume: 11, Issue:6 Topics: Adenylyl Cyclases; Amino Acid Sequence; Animals; Arginine Vasopressin; Cell Line; COS Cells; Diabetes Insipidus, Nephrogenic; Genes, Recessive; Humans; Molecular Sequence Data; Mutation; Receptors, Vasopressin; Sequence Deletion; X Chromosome	1997
Functional study of two V2 vasopressin mutant receptors related to NDI. P322S and P322H. Advances in experimental medicine and biology, 1998, Volume: 449 Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Arginine Vasopressin; Conserved Sequence; COS Cells; Diabetes Insipidus, Nephrogenic; Humans; Kinetics; Point Mutation; Rats; Receptors, Vasopressin; Recombinant Proteins; Transfection; X Chromosome	1998
Molecular analyses of the vasopressin type 2 receptor and aquaporin-2 genes in Brazilian kindreds with nephrogenic diabetes insipidus. Human mutation, 1999, Volume: 14, Issue:3 Topics: Adolescent; Adult; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Brazil; Child; Diabetes Insipidus, Nephrogenic; DNA Mutational Analysis; Electrophoresis, Polyacrylamide Gel; Female; Humans; Infant; Male; Mutation; Pedigree; Polymerase Chain Reaction; Polymorphism, Genetic; Receptors, Vasopressin; Sequence Analysis, DNA; Sweden	1999
A novel mutation in the vasopressin V2 receptor gene in a woman with congenital nephrogenic diabetes insipidus. Internal medicine (Tokyo, Japan), 1999, Volume: 38, Issue:10 Topics: Amino Acid Sequence; Arginine Vasopressin; Base Sequence; Diabetes Insipidus, Nephrogenic; Drug Resistance; Female; Fluid Therapy; Gastrointestinal Neoplasms; Humans; Middle Aged; Molecular Sequence Data; Mutation, Missense; Receptors, Vasopressin; Renal Agents	1999
Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. The Journal of clinical investigation, 2000, Volume: 105, Issue:7 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Cell Line; Cell Membrane; COS Cells; Diabetes Insipidus, Nephrogenic; Flow Cytometry; Humans; Intracellular Fluid; Molecular Chaperones; Morpholines; Mutagenesis; Protein Folding; Pyrroles; Receptors, Vasopressin; Spiro Compounds	2000
Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families. The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:4 Topics: Amino Acid Sequence; Animals; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Child; Child, Preschool; COS Cells; Deoxyribonucleases, Type II Site-Specific; Diabetes Insipidus, Nephrogenic; DNA Mutational Analysis; Female; Genetic Linkage; Humans; Infant; Male; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Mutation, Missense; Pedigree; Polymerase Chain Reaction; Receptors, Vasopressin; Sequence Alignment; Transfection; X Chromosome	2000
Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus. Proceedings of the National Academy of Sciences of the United States of America, 2001, Jan-02, Volume: 98, Issue:1 Topics: Adenylyl Cyclases; Amino Acid Substitution; Arginine Vasopressin; Arrestins; beta-Arrestins; Cell Line; Cell Membrane; Diabetes Insipidus, Nephrogenic; Dynamins; Endocytosis; GTP Phosphohydrolases; Humans; Microscopy, Fluorescence; Mutation; Phenotype; Phosphorylation; Precipitin Tests; Protein Binding; Receptors, Vasopressin; Recombinant Proteins; Signal Transduction; Transfection	2001
Water intake and 24-hour blood pressure monitoring in a patient with nephrogenic diabetes insipidus caused by a novel mutation of the vasopressin V2R gene. Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:2 Topics: Arginine Vasopressin; Blood Pressure Monitoring, Ambulatory; Diabetes Insipidus, Nephrogenic; DNA Mutational Analysis; Drinking; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Pedigree; Polymerase Chain Reaction; Receptors, Vasopressin; Sequence Deletion; Water Deprivation	2002